ASLAN Pharmaceuticals Provides TREK-DX Study Update and...
a clinical-stage, immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that it has begun to enroll patients in the US under an updated protocol in the ongoing TREK-D...